Evidence map›Paper›PMID 39229650›Full record

ArticleAmerican journal of medical genetics. Part A2025

Genetic Contributions to Lower Urinary Tract Dysfunction.

Lilian R Hiltebeitel, Steve Seltzsam, Chunyan Wang, Ted Lee, Leah Bolsius, Mohamed Shalaby, Sherif El Desoky, Jameela A Kari, Shirlee Shril, Friedhelm Hildebrandt and 1 more

Abstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lilian R HiltebeitelDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.ORCID 0009-0003-7797-4217
Steve SeltzsamDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.
Chunyan WangDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.
Ted LeeDepartment of Urology, Boston Children's Hospital, Harvard Medical School, Boston, United States.
Leah BolsiusDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.
Mohamed ShalabyPediatric Nephrology Centre of Excellence, King Abdulaziz University, Jeddah, Saudi Arabia.
Sherif El DesokyPediatric Nephrology Centre of Excellence, King Abdulaziz University, Jeddah, Saudi Arabia.
Jameela A KariPediatric Nephrology Centre of Excellence, King Abdulaziz University, Jeddah, Saudi Arabia.
Shirlee ShrilDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.
Friedhelm HildebrandtDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.ORCID 0000-0002-7130-0030
Nina MannDivision of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, United States.ORCID 0000-0001-8761-7633

Funding

Novel genetics, pathobiology & therapy of nephronophthisis-related ciliopathiesR01DK068306 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2004 to 2022
$6.6M
Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
Discovery and pathogenic characterization of novel monogenic causes of bladder dysfunction-Administrative supplementK08DK127011 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI MANN, NINA · 2021 to 2025
$901k
Begg Family FoundationBoston Children's Hospital Office of Faculty Development/Basic & Clinical Translational Research Executive Committees Faculty Career Development FellowshipNIDDK NIH HHS K08 DK127011NIDDK NIH HHS R01 DK068306NIDDK NIH HHS R01 DK076683NIH HHS DK068306NIH HHS DK076683NIH HHS K08-DK127011
6 · The paper itself

Abstract

Lower urinary tract dysfunction (LUTD) can manifest as a spectrum of voiding symptoms in childhood, including urinary urgency, frequency, hesitancy, and incontinence. In severe cases, it can lead to frequent urinary tract infections, hydronephrosis, kidney scarring, and chronic kidney disease. Non-neurogenic neurogenic bladder (NNNB) is a diagnosis of exclusion in which children develop discoordination between the detrusor smooth muscle and external urethral sphincter in the absence of neurological or obstructive lesions, resulting in severe LUTD. Historically, such disorders of voiding were thought to result from behavioral maladaptation. However, it is now increasingly recognized that some individuals may have an underlying genetic etiology for their symptoms. Here, we performed exome sequencing for five probands with NNNB or other forms of severe LUTD, and we identified two individuals with monogenic etiologies for their symptoms. One individual had a homozygous exon 9 deletion in HPSE2 and another had a homozygous single amino acid deletion (p.Gly167del) in ARL6. We performed PCR experiments to identify the breakpoints of the HPSE2 exon 9 deletion and implicate microhomology-mediated end joining as a potential mechanism by which the deletion arose. These findings suggest that genetic testing should be considered for children with severe LUTD.

Indexed as

Exome SequencingExonsGenetic Predisposition to DiseaseHumansLower Urinary Tract SymptomsSequence DeletionUrinary Bladder, Neurogenicexome sequencinglower urinary tract dysfunctionnon‐neurogenic neurogenic bladderurofacial syndrome

Identifiers

PMID39229650
PMCPMC11637931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.